基础医学与临床 ›› 2024, Vol. 44 ›› Issue (7): 947-953.doi: 10.16352/j.issn.1001-6325.2024.07.0947

• 研究论文 • 上一篇    下一篇

过表达膜定位IL-3的293T细胞外泌体的纯化及体外功能验证

高璐1, 蔡孟华1,2, 许依1,2, 何维1, 陈慧1,2, 张建民1,2*   

  1. 1.中国医学科学院基础医学研究所 北京协和医学院基础医学院 免疫学系 中国医学科学院T细胞与免疫治疗重点实验室 重大疾病共性机制研究全国重点实验室,北京 100005;
    2.常州西太湖细胞治疗前沿技术研究院,江苏 常州 213000
  • 收稿日期:2024-03-19 修回日期:2024-04-29 出版日期:2024-07-05 发布日期:2024-06-26
  • 通讯作者: *jzhang42@163.com
  • 基金资助:
    国家自然科学基金(82071791,32300745);中国医学科学院创新工程(2021-I2M-1-035)

Purification and in vitro functional validation of exosomes from 293T cells with over-expressed membrane-localized IL-3

GAO Lu1, CAI Menghua1,2, XU Yi1,2, HE Wei1, CHEN Hui1,2, ZHANG Jianmin1,2*   

  1. 1. Department of Immunology, Key Laboratory for T Cell and Immunotherapy CAMS, State Key Laboratory of Common Mechanism Research for Major Disease, Institute of Basic Medical Sciences CAMS, School of Basic Medicine PUMC,Beijing 100005;
    2. Changzhou Xitaihu Institute for Frontier Technology of Cell Therapy, Changzhou 213000, China
  • Received:2024-03-19 Revised:2024-04-29 Online:2024-07-05 Published:2024-06-26
  • Contact: *jzhang42@163.com

摘要: 目的 体外验证过表达膜定位IL-3的293T细胞外泌体的功能,为在阿尔茨海默病模型动物的体内功能验证奠定基础。方法 利用本课题组的专利结构,构建能定位于外泌体膜上的重组IL-3慢病毒载体,包装病毒感染293T细胞,筛选稳定表达细胞株。用流式细胞测量术和免疫荧光技术对IL-3的膜定位进行验证;超滤离心纯化IL-3外泌体,透射电镜观察外泌体形态;纳米流式测量术检测外泌体粒径分布及浓度;Western blot检测IL-3及外泌体相关标志蛋白质表达;免疫荧光技术检测其对小胶质细胞系BV-2吞噬Aβ淀粉样蛋白能力的影响。结果 经过载体构建、病毒感染、嘌呤霉素筛选和验证,得到稳定过表达膜定位IL-3的293T细胞株;收集纯化外泌体,在透射电镜下可见直径50~100 nm的双层膜囊泡结构;免疫印迹结果显示CD63、ALIX、TSG101等多种外泌体标志蛋白质检测阳性,且与对照相比富含IL-3,提示IL-3外泌体纯化成功;免疫荧光技术检测结果显示IL-3外泌体能在体外促进BV-2细胞对Aβ淀粉样蛋白的吞噬作用。结论 过表达膜定位IL-3的基因修饰293T细胞外泌体在体外兼具IL-3和外泌体的作用,能够促进小胶质细胞的吞噬作用,为阿尔茨海默病的临床治疗提供新的思路。

关键词: 白细胞介素3(IL-3), 外泌体, 小鼠脑小胶质细胞系(BV-2), 阿尔茨海默病

Abstract: Objective To verify the function of exosomes from 293T cells over-expressing membrane-localized IL-3 in vitro, so as to lay a foundation for in vivo function verification in animal models of Alzheimer′s disease. Methods Using the patented structure of the group, a recombinant IL-3 lentiviral vector was constructed and virus-infected 293T cells were packaged. Stable cell strain over-expressing IL-3 was screened. The membrane localization of IL-3 was verified by flow cytometry and immuno-fluorescence. Il-3-exosomes were purified by ultra filtration centrifugation, the exosmic morphology was observed by transmission electron microscope, the size distribution and concentration of exosomes were detected by nano-flow analysis, and the expression of IL-3 and exosome related marker proteins were detected by Western blot. The effect of BV-2 on the phagocytosis of Aβ amyloid was detected by immuno-fluorescence. Results Through vector construction, virus infection, screening and verification of puromycin, 293T cell strain with stable over-expression membrane-anchored IL-3 was obtained. The purified exosomes were collected and the structures of double-layer membrane vesicles with a diameter of 50-100 nm were observed under transmission electron microscope. Western blot results proved the presence of CD63, ALIX, TSG101 and other exosome marker proteins and these molecules were rich in IL-3 as compared with the control, that suggested the successful purification of IL-3-exosomes. The results of immuno-fluorescence assay showed that IL-3-exosomes promoted the phagocytosis of Aβ amyloid by BV-2 cells in vitro. Conclusions The gene modified 293T cell exosomes membrane-anchored expression of IL-3 can play a role of both IL-3 and exosomes in vitro, which promote the phagocytosis of microglia, there for provides a new idea for the clinical treatment of Alzheimer′s disease.

Key words: interleukin-3(IL-3), exosome, mouse brain microglial cell line(BV-2), Alzheimer′s disease

中图分类号: